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Adenylyl Cyclase 6 Deletion Reduces
Left Ventricular Hypertrophy, Dilation, Dysfunction,
and Fibrosis in Pressure-Overloaded Female Mice
Tong Tang, PHD,*† N. Chin Lai, PHD,*† H. Kirk Hammond, MD,*† David M. Roth, MD, PHD,*‡
Yuan Yang, MD,† Tracy Guo, BS,† Mei Hua Gao, PHD*†
San Diego, California
Objectives This study sought to test the hypothesis that pressure stress of the adenylyl cyclase 6-deleted (AC6-KO) heart
would result in excessive hypertrophy, early dilation and dysfunction, and increased fibrosis.
Background Cardiac-directed AC6 expression attenuates left ventricular (LV) hypertrophy and dysfunction in cardiomyopathy.
Methods AC6-KO and control (CON) mice underwent transverse aortic constriction (TAC) to induce pressure overload. Mea-
sures of LV hypertrophy, function, and fibrosis were obtained 3 weeks after TAC, and LV samples were assessed
for alterations in expression of FHL1 and periostin.
Results Three weeks after TAC, female AC6-KO mice had preserved left ventricular (LV) ejection fraction (CON: 22  2%;
AC6-KO: 52  4%; p  0.001) and reduced LV end-diastolic dimension (CON: 4.6  0.1 mm; AC6-KO: 3.6  0.1
mm; p  0.001). Reduced LV/tibial length ratio (CON: 10.4  1.5 mg/mm; AC6-KO: 7.5  2.3 mg/mm; p 
0.001) and reduced LV expression of atrial natriuretic factor (p  0.05), -skeletal muscle actin (p  0.05), and
beta-myosin heavy chain (p  0.05) were observed in AC6-KO mice. In addition, AC6 deletion was associated
with less LV fibrosis (p  0.01) and reduced collagen types I (p  0.05) and III (p  0.05) expression 3 weeks
after TAC. LV protein expression of FHL1 (p  0.02) and periostin (p  0.04) were reduced after TAC in AC6-KO
mice. The roles of AC6 deletion in cardiac myocytes and fibroblasts were examined in vitro using pharmacologi-
cal hypertrophy and AC6 knockdown (small interfering ribonucleic acid), which recapitulated in vivo findings.
Conclusions The deleterious effects of LV pressure overload were reduced in female mice with AC6 deletion. Reductions in
FHL1 and periostin expression, direct consequences of reduced AC6 in cardiac myocytes and fibroblasts, appear
to be of mechanistic importance for these unanticipated beneficial effects. (J Am Coll Cardiol 2010;55:
1476–86) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.066a
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cardiac-directed expression of adenylyl cyclase (AC) atten-
ates left ventricular (LV) hypertrophy in cardiomyopathy
1), suggesting a link between AC6 and signaling pathways
egulating LV hypertrophy. We reasoned that use of the
otentially superior strategy of AC6 gene deletion (vs.
ain-of-function) in a dissimilar model of hypertrophy
pressure overload) would help delineate how AC6 influ-
nces hypertrophy. For example, LV pressure overload, by
ctivating different signaling pathways than those seen with
ardiomyopathy, would provide insight regarding how AC6
nfluences the hypertrophic response. Furthermore, this
rom the * VA San Diego Healthcare System and the Departments of †Medicine and
Anesthesiology, University of California San Diego, San Diego, California. This
ork was supported by Beginning Grants-In-Aid from the American Heart Associ-
tion Western States Affiliate (Drs. Tang and Gao), NIH grants P01HL066941,
L081741, and HL088426), and VA Merit Review Awards.a
Manuscript received June 25, 2009; revised manuscript received November 5, 2009,
ccepted November 9, 2009.pproach might also enable us to identify potential targets
or treating the dysfunctional heart.
Chronic pressure overload, such as occurs with persistent
ypertension, is associated with a higher risk of the devel-
pment of clinical heart failure. Although this process
enerally takes decades to develop in patients, severe LV
ressure overload associated with transverse aortic constric-
ion (TAC) leads to LV hypertrophy and impaired LV
unction in weeks in mice, thereby providing an efficient
odel to study the effects of AC6 deletion (2) on the
ressure-stressed LV.
AC5 and AC6, the predominant adenylyl cyclase types in
ardiac myocytes (2,3), have been associated with altered
ell survival, fibrosis, and collagen production. For example,
C5 deletion reduces apoptosis in pressure overload (4) and
ecreases fibrosis in the aging heart (3). AC6 influences
ardiac fibroblast function in vitro (5). TAC, which is
ssociated with increased LV fibrosis, therefore, is a well-
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April 6, 2010:1476–86 Adenylyl Cyclase Knockout and Pressure Overloaduited model to use to determine whether AC6 deletion
lters LV fibrosis in pressure overload.
Previous reports have shown that increased levels of
ardiac AC6 have beneficial effects on the normal heart, in
cute myocardial infarction, in congestive heart failure due
o myocardial infarction, in pacing congestive heart failure
n pigs, and murine cardiomyopathy (1,6–8). In addition,
C6 deletion impairs LV function in otherwise normal
ice (2). Our hypothesis, therefore, was that pressure stress
f the AC6-deleted heart would result in excessive hyper-
rophy, early dilation and dysfunction, and increased
brosis.
ethods
nimals. Three- to 6-month-old homozygous AC6-
eleted mice (AC6-KO) and their littermate control mice
CON) were used in this study (2). These mice have a
ongenic C57BL/6 genetic background because this
C6-KO line has been back-crossed with C57BL/6 (Har-
an Laboratories, Indianapolis, Indiana) for more than 10
enerations. Genotyping was performed using genomic
NA purified from tail clip as previously described (2).
bsence of AC6 protein expression was confirmed by
estern blotting. The Animal Use and Care Committee of
he VA San Diego Healthcare System, in accordance with
ssociation for Assessment and Accreditation of Labora-
ory Animal Care guidelines, approved this study.
AC. Mice were anesthetized with 5% isoflurane in
xygen (1 l/min), intubated, and ventilated (pressure-
ontrolled). Anesthesia was maintained with 1% isoflurane
n oxygen. The chest was entered at the second intercostal
pace at the left upper sternal border, and a segment of the
ortic arch between the innominate and left carotid arteries
issected. A 7-0 silk suture was tied against a 27-gauge
eedle, which yields a substantial aortic constriction.
Figure 1 Kaplan-Meier Analysis Showing Survival After TAC in A
(A) No group difference in mortality 3 weeks after transverse aortic constriction (T
adenylyl cyclase (AC) 6-deleted mice (p  0.07 vs. control mice [CON]) 3 weeks a
mice, in which the mortality rate of both groups was 60%. Because 75% of male A
performed only in female mice. Numbers in parentheses indicate group sizes. KOchocardiography. Echocar-
iography was performed with
he mice under light anesthesia
efore and 3 weeks after TAC
sing previously reported meth-
ds (2). Interobserver variability
or murine echocardiography
easurements in our laboratory
s small, with a very tight corre-
ation between 2 independent
eaders (r2  0.89).
V physiological studies. A 1.4-F
onductance-micromanometer
atheter was used to measure
V hemodynamics using a
losed chest method, as pre-
iously reported (7) (see also
nline Supplement).
ecropsy and LV fibrosis assessment. Body and LV
eights (including the septum) and tibial lengths were re-
orded. A short-axis mid-wall LV ring was formalin fixed and
araffin embedded. Dewaxed sections (6 m) were rehydrated,
tained with picrosirius red (1 h), and counterstained with
ematoxylin (1 min). LV sections were then dehydrated using
raded concentrations of ethanol and mounted in Permont.
ollagen fractional area was quantified using NIH Image J
oftware.
uantitative reverse transcriptase-polymerase chain
eaction (RT-PCR). See the Online Supplement.
estern blotting. See the Online Supplement.
elatin zymography. See the Online Supplement.
harmacological hypertrophy and AC6 knockdown in
ultured cardiac myocytes and fibroblasts. We isolated
ardiac myocytes and fibroblasts from 2-day-old Sprague-
awley rats as previously reported (9). Left ventricles
ere minced and digested with collagenase II and pan-
eleted Mice and Their Intact Littermates
s observed in male and female mice combined. (B) Mortality was 83% in male
C. (C) No group difference was seen in mortality 3 weeks after TAC in female
leted mice were dead 1 week after TAC, biochemical and molecular studies were
-deleted mice.
Abbreviations
and Acronyms
AC  adenylyl cyclase
AC6-KO  AC6-deleted
mice
CON  control mice
LV  left ventricular
mRNA  messenger
ribonucleic acid
RT-PCR  reverse
transcriptase-polymerase
chain reaction
siRNA  small interfering
ribonucleic acid
TAC  transverse aortic
constrictionC6-D
AC) wa
fter TA
C6-de
 AC6
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Adenylyl Cyclase Knockout and Pressure Overload April 6, 2010:1476–86reatin at 37°C. The dissociated cardiac cells were cen-
rifuged through discontinuous Percoll gradients to sep-
rate cardiac myocytes, fibroblasts, and other cardiac cell
ypes. Isolated cardiac fibroblasts were washed with
hosphate-buffered saline and cultured overnight at 37°C
n Dulbecco’s modified Eagle medium supplemented
ith 10% fetal bovine serum; isolated cardiac myocytes
ere washed with phosphate-buffered saline, seeded in
elatin-coated dishes, and cultured overnight at 37°C in
ulbecco’s modified Eagle medium supplemented with
0% fetal bovine serum and 5% horse serum. Transfec-
ion of rat AC6 small interfering ribonucleic acid
siRNA) (ON-TARGETplus SMARTpool L-100104-
1-0010, Dharmacon, Lafayette, Colorado) was achieved
y using X-tremeGENE siRNA Transfection Reagent
Cat. #04476093001, Roche, Indianapolis, Indiana) ac-
ording to the manufacturer’s instructions. Twenty-four
ours after AC6 siRNA transfection, cells were starved
A B
1 
m
m
CON KO
pre TAC
3w TAC
100 ms
1 
m
m
0
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Figure 2 Reduced LV Dilation and Preserved LV Function 3 We
(A) Echocardiogram of a control (CON) mouse shows greater left ventricular (LV) d
cyclase 6-deleted (KO) mouse). (B) AC6-deleted mice showed preserved LV ejectio
deleted mice, showed LV dilation 3 weeks after TAC. There were no group differen
and p value for AC6 effect is shown in upper left corner of B and C. p Values abo
1 SE; numbers in bars  group size. LVEDD  left ventricular end-diastolic diame
chocardiography MeasurementsTable 1 Echocardiography Measurements
Before TAC
CON (n  28) AC6-KO (n  21)
End-diastolic diameter (mm) 3.7 0.1 3.5 0.1
End-systolic diameter (mm) 2.4 0.1 2.2 0.1
Posterior wall thickness (mm) 0.7 0.01 0.6 0.01
IVS wall thickness (mm) 0.7 0.01 0.7 0.01
Heart rate (beats/min) 491 13‡ 487 11§
Ejection time (ms) 48 1 47 1¶
LV fractional shortening (%) 35 1 36 1
LV ejection fraction (%) 65 2 66 2
Vcf (circ/s) 7.4 0.3 7.9 0.4¶
p  0.01 vs. CON mice before TAC from post hoc testing. †p  NS vs. AC6-KO mice before TAC fr
ost hoc testing. p Values are from 2-way analysis of variance for interaction (Inter), AC6 effect, and TAC
AC6-KO  AC6-deleted mice; CON  control mice; IVS  interventricular septum; LV  left ventricularor 8 h and then treated with 20 mol/l phenylephrine or
00 nmol/l angiotensin II for 16 h. Total RNA was
xtracted and purified, and quantitative RT-PCR was
erformed to compare messenger ribonucleic acid
mRNA) contents using glyceraldehyde-3-phosphate de-
ydrogenase as internal control. AC6 siRNA specifically
nocked down AC6 mRNA expression and did not alter
RNA expression of AC5, another cardiac adenylyl
yclase isoform with high homology to AC6. To compare
rotein contents of FHL1 and periostin, cells were
omogenized in homogenization buffer in the presence of
rotease inhibitors. Denatured cell homogenates in Lae-
mli buffer were subject to sodium dodecyl sulfate–
olyacrylamide gel electrophoresis and Western blotting,
s stated previously.
The presence of hypertrophy was evaluated by assessment
f cardiac myocyte size. Photomicrographs of cardiac myo-
ytes were obtained in randomly selected areas using a
C
 TAC 3w TAC
<0.01
  KO    CON  KO
2821 21
0001
0.0
2.0
4.0
6.0
Pre TAC 3w TAC
<0.01
CON   KO    CON  KO
28 2821 21
L
V
E
D
D
 (
m
m
)
p<0.0001
fter TAC in AC6-Deleted Mice
3 weeks (3w) after transverse aortic constriction (TAC) versus an adenylyl
tion (EF) 3 weeks after TAC versus control mice. (C) Control mice, but not AC6-
heart rate. Two-way analysis of variance was performed for statistical analysis
s are from post-hoc testing (CON vs. KO, 3 weeks [3w] after TAC). Error bars 
3 Weeks After TAC p Value
n  28) AC6-KO (n  21) Inter AC6 Effect TAC Effect
 0.1* 3.6 0.1 0.001 0.001 0.001
 0.1* 2.6 0.2† 0.001 0.001 0.001
 0.02 1.0 0.04 0.78 0.79 0.001
 0.02 1.0 0.03 0.61 0.89 0.001
 9‡ 507 12§ 0.69 0.43 0.03
 1 50 1¶ 0.49 0.63 0.003
 1 27 2 0.001 0.001 0.001
 2 52 4 0.001 0.001 0.001
 0.2* 5.5 0.5¶# 0.001 0.001 0.001
t hoc testing. ‡n  26. §n  20. n  27. ¶n  19. #p  0.01 vs. AC6-KO mice before TAC fromPre
CON
28
p<0.
eks A
ilation
n frac
ces in
ve bar
ter.CON (
4.6
4.1
0.9
1.0
521
51
10
22
2.1
om pos
effect. Values shown are mean  SE.
; TAC  transverse aortic constriction; Vcf  velocity of circumferential fiber shortening.
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t test (2-tailed). Values shown are mean  SE. *n  12. †n  7. ‡n  9. §n  8.
LV  left ventricular; PRSW  preload recruitable stroke work.
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April 6, 2010:1476–86 Adenylyl Cyclase Knockout and Pressure Overloadikon microscope. Cell area was measured with NIH
mage J software, and only cardiac myocytes with an area
20 m2 were used. Cardiac myocytes that were adjoining or
poptotic in appearance were excluded from the analyses.
tatistical analysis. Results are shown as mean  SE.
roup differences in mortality were assessed using Kaplan-
eier analysis and the log-rank test. Group means of other
ata were compared using Student t test (unpaired, 2-tailed) or
-way analysis of variance with post hoc comparisons made
sing t testing. Multiple comparisons were corrected using the
onferroni method. The null hypothesis was rejected when
 0.05. Data from echocardiography and physiology studies
ere collected and analyzed blinded to group identity.
esults
ortality. No group difference in mortality was observed 3
eeks after TAC in male and female mice combined
CON: 61%; AC6-KO: 67%; p  0.45), or in female mice
TAC
tance (slope of the end-systolic pressure-volume relationship). (B) The bar
led). Error bars  1 SE; numbers in bars  group size. Abbreviations as inFigure 3 Effects of AC6 Deletion on LV Contractility 3 Weeks After
(A) LV pressure-volume loops, generated by altering LV preload, are shown with elas
graph summarizes data from all animals. p Value shown is from Student t test (2 tai
Figure 1.eft Ventricular Physiology 3 Weeksfter Transaortic ConstrictionTable 2 Left Ventricular Physiology 3 WeeksAfter Transaortic Constriction
CON
(n  15)
AC6-KO
(n  11) p Value
Heart rate (beats/min) 453 14 432 16 0.34
Cardiac output (ml/min) 2.2 0.4* 3.6 0.3† 0.01
Stroke volume (l) 5 1 8 1 0.05
LV pressure (mm Hg) 87 6 93 5 0.45
Stroke work (mm Hg·l) 176 45* 490 62† 0.002
LV dP/dt (mm Hg/s) 2,793 251 3,610 406 0.05
LV dP/dt (mm Hg/s) 2,842 343 3,895 286 0.07
LV end-diastolic pressure
(mm Hg)
13 2 7 1 0.03
Tau (ms) 7.1 0.3 6.6 0.2 0.19
LV elastance (mm Hg/l) 3.8 0.7‡ 7.7 0.7* 0.002
PRSW (mm Hg) 26 6§ 58 9* 0.02
lastance is the slope of the end-systolic pressure-volume relationship. p Values are from Student
(
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owever, male AC6-deleted mice tended to have higher
ortality rates (CON: 62%; AC6-KO: 83%; p  0.07)
Fig. 1B). Indeed, almost 75% of male AC6-KO mice died
ithin 1 week of TAC, necessitating that biochemical and
olecular studies over the 3-week course be conducted in
emale mice alone. The control group (both sexes com-
ined) showed 61% mortality, higher than that of a previous
eport (10). This likely reflects a strain difference. Although
57BL/6J mice show only 20% to 50% mortality rates 3
eeks after TAC, the C57BL/6 strain, which were used in
he present study, have a higher mortality rate.
chocardiography. There was a decline in LV function in
ressure-overloaded hearts of CON mice. There was a
elative reduction of 66% in LV ejection fraction in CON
ice 3 weeks after TAC; AC6-deleted mice showed a 22%
elative reduction (Figs. 2A and 2B, Table 1). CON mice
howed LV dilation 3 weeks after TAC, but AC6-deleted
ice showed no LV dilation (Figs. 2A and 2C, Table 1).
eart rates showed no group differences during echocardi-
graphy studies (Table 1).
V physiological studies. Three weeks after TAC-induced
ressure overload, AC6-deleted mice showed higher stroke
olume, stroke work, and LVdP/dt (Table 2); heart rate for
oth groups was similar. LV dP/dt for the AC6-deleted
Figure 4 Reduced LV Hypertrophy 3 Weeks After TAC in AC6-D
(A) There was substantial LV hypertrophy 3 weeks after TAC, which was attenuate
tibial length ratio versus control mice 3 weeks after TAC. (C, D, E) AC6 deletion re
atrial natriuretic factor (ANF), -skeletal muscle actin (SK actin), and -myosin hea
AC6 deletion effect (p  0.05). p Values above bars are from post-hoc testing (CO
LV/TL  left ventricular/tibial length; other abbreviations as in Figures 1 and 2.roup tended to be lower than that for CON (Table 2).
ardiac output was higher in AC6-deleted mice 3 weeks
fter TAC (Table 2), and LV elastance, a measure of LV
ontractility, was 2-fold higher (p  0.002) (Fig. 3, Table 2).
V hypertrophy. Hearts from CON mice showed greater
V hypertrophy than hearts of AC6-deleted mice (Fig.
A). The LV weight/tibial length ratio increased from 6.5
g/mm to 10.4 mg/mm in CON, but increased from 6.0
g/mm to 7.5 mg/mm in AC6-deleted mice 3 weeks after
AC (p  0.001) (Fig. 4B). LV samples from pressure-
verloaded CON mice showed increased expression of atrial
atriuretic factor (Fig. 4C), -skeletal muscle actin (Fig.
D), and -myosin heavy chain (Fig. 4E). In contrast, LV
amples from AC6-deleted mice showed less expression of
hese genes (Figs. 4C to 4E). These data indicate that AC6
eletion not only reduces LV hypertrophy in response to
ressure overload, but also is associated with reduced ex-
ression of fetal genes.
V fibrosis. As shown in the bright-field microscopic
mages (Fig. 5A), there was less collagen deposition in
ections of the left ventricles from AC6-deleted mice under
ressure overload stress compared with those from CON
ice. Quantification by NIH Image J software revealed that
C6 deletion decreased the collagen fractional area in
d Mice
C6-deleted mice (AC6-KO). (B) AC6-deleted mice showed reduced LV weight/
LV expression (quantitative reverse transcriptase-polymerase chain reaction) of
in (MHC) 3 weeks after TAC. Two-way analysis of variance showed a significant
KO, 3 weeks after TAC). Error bars  1 SE; numbers in bars  group size.elete
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April 6, 2010:1476–86 Adenylyl Cyclase Knockout and Pressure Overloadressure-overloaded hearts (CON: 14 3%, AC6-KO: 6
%; p  0.01, n  6) (Fig. 5B).
To determine whether reduced collagen deposition was
ssociated with reduced collagen expression, we compared
ollagen mRNA content in LV samples from CON and
C6-deleted mice by quantitative RT-PCR (Figs. 5C and
D). Pressure overload of AC6-KO mice was associated
ith reduced LV mRNA expression of types I (p  0.05)
nd III (p  0.05) collagen, 2 major constituents of the
xtracellular connective tissue matrix contributing approxi-
ately 95% of the total collagen content in the heart (11).
hese data indicate that AC6 deletion decreases LV colla-
en gene expression and LV fibrosis 3 weeks after TAC.
V expression of genes associated with hypertrophy and
brosis. GATA4 expression was increased in pressure-
verloaded hearts, as previously reported (12), but was
naffected by AC6 deletion (Figs. 6A and 6B). AC6
eletion did not alter LV protein expression of HDAC5,
hospho-HDAC5, GSK-3, or phospho-GSK3 3 weeks
Figure 5 AC6 Deletion Reduced LV Fibrosis 3 Weeks After TAC
(A) Images of picrosirius red stained LV sections 3 weeks after TAC. (B) Analysis
bar) from Student t test (2-tailed). AC6 deletion reduced expression of collagen I 
effect (p  0.05). p Values above bars are from post hoc testing (CON vs. KO, 3 w
in Figures 1, 2, and 4.fter TAC (data not shown). wWe assessed expression of elements of the -adrenergic
eceptor signaling pathway and found that AC6 deletion
ecreased NKH477-stimulated cyclic adenosine mono-
hosphate generation in LV homogenates from pressure-
verloaded hearts (CON: 197  14 fmol/min/g; AC6-
O: 70  11 fmol/min/g; p  0.0001, n  8), as was
nticipated (2). Protein contents of PDE3A and PDE4D, 2
mportant cyclic adenosine monophosphate–hydrolyzing
hosphodiesterases in cardiac myocytes, were not altered
Online Appendix). Furthermore, we found that AC6
eletion did not alter mRNA contents of adenylyl cyclase
soforms (AC2, 3, 4, 5, 7, and 9) in pressure-overloaded
earts (Online Appendix). The absence of LV AC5 protein
n AC6-deleted mice was noted 3 weeks after TAC (data
ot shown), a finding similar to what we reported previously
n AC6-deleted mice (2).
We then focused on FHL1, a protein associated with the
ontractile apparatus that appears to be required for pressure
verload-induced LV hypertrophy (13). No group differences
less collagen fractional area in LV samples from AC6-KO mice; p value (above
and collagen III 1 (D). Two-way analysis of variance showed a significant AC6
after TAC). Error bars  1 SE; numbers in bars  group size. Abbreviations asshows
1 (C)
eeksere seen in LV FHL1 protein expression pre-TAC. However,
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Adenylyl Cyclase Knockout and Pressure Overload April 6, 2010:1476–86he increase in FHL1 expression associated with pressure overload
as inhibited by AC6 deletion (Fig. 6C). Western blotting
onfirmed that AC6 deletion reduced LV FHL1 protein content
y 51% 3 weeks after TAC (p  0.02) (Fig. 6D).
Quantitative RT-PCR showed that periostin mRNA
ontent was increased by pressure overload, and the increase
n mRNA content of periostin, a regulator of cardiac
brosis, was attenuated by AC6 deletion (Fig. 7A). AC6
eletion decreased LV periostin protein content by 53% 3
eeks after TAC (Fig. 7B). Matrix metalloproteinase 2
RNA expression was increased in pressure-overloaded
earts, as previously reported (14), but was unaffected by
C6 deletion (Fig. 7C); matrix metalloproteinase 2 gelati-
ase activity was not altered by AC6 deletion (data not
hown).
ultured cardiac myocytes. Transfection of cardiac myo-
ytes with AC6 siRNA specifically decreased AC6 mRNA
xpression by 88% (Fig. 8A). Knockdown of AC6 decreased
henylephrine-induced hypertrophy of cardiac myocytes
Figure 6 LV GATA4 and FHL1 Expression
(A) LV GATA4 messenger ribonucleic acid (mRNA) expression increased 3 weeks a
GATA4 protein expression was similar in both groups 3 weeks after TAC. LV FHL1
mice. Gene expression was assessed by quantitative real-time polymerase chain r
SE; numbers in bars  group size. du  densitometric unit; GAPDH  glyceraldehTable 3) and reduced mRNA expression of atrial natri- rretic factor and -myosin heavy chain (Figs. 8B and 8C).
henylephrine- and angiotensin II–induced cardiac myo-
yte hypertrophy were both inhibited by reductions in AC6,
ndicating that AC6 levels influence Gq-mediated hyper-
rophy. Just as was the case in vivo, reduced AC6 content
ecreased protein expression of FHL1 in phenylephrine-
timulated cultured cardiac myocytes (Fig. 8G). These
esults suggest that reduction of AC6 decreases hypertrophy
y decreasing expression of FHL1 in cardiac myocytes.
ultured cardiac fibroblasts. Transfection of cardiac fi-
roblasts with AC6 siRNA specifically decreased AC6
RNA expression by 71% (Fig. 8D). AC6 knockdown
educed mRNA expression of collagen types I and III (Figs.
E and 8F). AC6 knockdown also decreased expression of
eriostin (Fig. 8H). These results indicate that reduction of
C6 directly decreases gene expression related to fibrotic
esponses in cardiac fibroblasts.
AC in male AC6-deleted mice. Almost 75% of male
C6-KO mice died within 1 week of TAC, and very few
C from similar pre-TAC levels; no group differences were observed. (B) LV
(C) and protein expression (D) were reduced 3 weeks after TAC in AC6-deleted
n and Western blotting; p values from Student’s t test (2-tailed). Error bars  1
dehydrogenase; other abbreviations as in Figures 1 and 2.fter TA
mRNA
eactio
yde-3-emained after 3 weeks—insufficient numbers to evaluate in
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April 6, 2010:1476–86 Adenylyl Cyclase Knockout and Pressure Overloadstatistically meaningful way. The male AC6-KO mice that
urvived 1 week of TAC, when compared with their female
ohorts, had lower ejection fractions, more LV dilation and
ypertrophy, and reduced LV fetal gene expression. Expres-
ion of FHL1 and periostin mRNA was also higher in male
han in female AC-KO mice 1 week after TAC. These data
re presented in detail in the Online Supplement.
iscussion
he most important finding of this study is that AC6 deletion
s associated with attenuation of LV hypertrophy, absence of
V dilation, and relative preservation of LV function in female
ice in response to pressure overload. Reactivation of fetal
ene expression and expression of collagens (types I and III) are
educed in hearts from these AC6-deleted mice after pressure
verload. These striking alterations in the heart’s response to
ressure stress in the absence of AC6 were associated with
ecreased expression of FHL1 and periostin, 2 mediators for
ardiac hypertrophy and fibrosis.
educed LV FHL1 expression. It is intriguing that de-
reased expression of LV FHL1 and periostin is associated
ith relative preservation of cardiac function in pressure-
verloaded AC6-deleted mice. FHL1 is a protein in the
ontractile apparatus and belongs to the family of proteins
ith 4 complete LIM domains and an N-terminal half LIM
omain. Increased LV FHL1 expression has been reported
n cardiomyopathy associated with cardiac-directed expres-
ion of 1-adrenergic receptor and Gs (15) and in clinical
ypertrophic cardiomyopathy (16). FHL1-deleted mice
how reduced LV hypertrophy and dysfunction in pressure
verload (17). Our data indicate that reduced LV FHL1
xpression may be an important mechanism for reduced LV
ypertrophy and preserved LV function associated with
Figure 7 LV Periostin and MMP-2 Expression
(A) AC6 deletion reduced LV expression (quantitative reverse transcriptase-polyme
AC6 effect (p  0.05) for periostin mRNA expression; p value above bar from pos
ting) was reduced 3 weeks after TAC in AC6-deleted mice; p value above bar from
(quantitative reverse transcriptase-polymerase chain reaction) increased 3 weeks
1 SE; numbers in bars  group size. Abbreviations as in Figures 1, 2, and 6.C6 deletion. The precise mechanism linking AC6 dele- tion and reduced LV FHL1 expression in pressure overload
ill require additional studies, but it is noteworthy that we
ee reduced FHL1 expression acutely after combined AC6
nockdown and pharmacological hypertrophy in isolated
ardiac myocytes, suggesting a relationship between AC6
nd FHL1 in cardiac myocytes.
educed periostin expression. Periostin is an extracellular
atrix protein expressed predominantly by fibroblasts
18–20). In connective tissues, periostin interacts with
ollagen and increases collagen fibrillogenesis (19). Periostin
lso plays an important role in cardiac hypertrophy and
brosis. Pathological stress, such as pressure overload and
yocardial infarction, increases cardiac periostin expression.
ardiac-directed expression of periostin increases both
ging-associated LV hypertrophy and LV collagen deposi-
ion (18). In contrast, periostin deletion decreases cardiac
ypertrophy and fibrosis and preserves LV function after
ressure overload (18). Our data indicate that reduced LV
eriostin expression, a consequence of AC6 deletion in the
ressure-overloaded heart, may be an important mechanism
or reduced LV fibrosis and improved cardiac relaxation.
he precise mechanism linking AC6 deletion and reduced
V periostin expression in pressure overload will require
dditional studies, but it is noteworthy that we see reduced
eriostin expression acutely after AC6 knockdown in iso-
ated cardiac fibroblasts, suggesting a relationship between
C6 and periostin in cardiac fibroblasts.
C6 versus AC5 and LV function in pressure overload. AC5
nd AC6 are the AC types most abundantly expressed in
he heart (2,3). In previous studies, we have shown that
hese 2 AC types have different effects on cardiac function,
espite their homology in amino acid sequence (2). In the
resent study, we have shown that absence of AC6 reduces
hain reaction) of periostin. Two-way analysis of variance showed a significant
esting (CON vs. KO, 3 weeks after TAC). (B) LV periostin protein (Western blot-
nt t test (2-tailed). (C) LV matrix metalloproteinase (MMP)-2 mRNA expression
AC from similar pre-TAC levels; no group differences were observed. Error bars rase c
t-hoc t
Stude
after The LV hypertrophic response to pressure overload (Fig. 2).
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Adenylyl Cyclase Knockout and Pressure Overload April 6, 2010:1476–86n contrast, AC5 deletion does not impede the hypertrophic
esponse to pressure overload (4). Furthermore, LV Bcl2
xpression was unchanged by TAC in AC6-deleted mice
data not shown), but increased in AC5-deleted mice (4).
hese data provide further evidence that AC5 and AC6
lay divergent roles in regulating cardiac function under
athophysiological conditions.
tudies in isolated cardiac myocytes and fibroblasts. Our
C6 deletion line was whole body, not cardiac limited, so
t was important to determine whether the effects ob-
erved in vivo resulted from AC6 deletion in cardiac
yocytes and fibroblasts or instead reflected extracardiac
Figure 8 Cultured Cardiac Myocytes
AC6 knockdown by specific small interfering ribonucleic acid (siRNA) followed by p
reverse transcriptase-polymerase chain reaction) of AC6 (A), ANF (B), and -MHC
myocytes (G) Cultured cardiac fibroblasts. AC6 knockdown reduced mRNA express
periostin protein expression (Western blotting) in cultured cardiac fibroblasts (H).
CON. Error bars  1 SE. Data in A through F are from 3 independent experimentsffects such as altered renin-angiotensin-aldosterone sig- caling. Studies conducted in cultured cardiac myocytes
nd fibroblasts provided an answer to this question, but
lso enabled additional mechanistic insights. We used the
ombination of AC6 knockdown and pharmacological hyper-
rophy in cultured cardiac myocytes and established that
) phenylephrine- (Table 3) and angiotensin II–induced hy-
ertrophy (data not shown) were inhibited by AC6 knock-
own, indicating that AC6 levels influence Gq-mediated
ypertrophy; 2) AC6 knockdown reduced expression of atrial
atriuretic factor and -myosin heavy chain. Reinduction of
hese fetal genes is associated with a variety of LV hypertrophy
odels; and 3) reduced AC6 is associated with decreased
phrine stimulation (10 mol/l, 16 h) reduced mRNA expression (quantitative
d also reduced FHL1 protein expression (Western blotting) in cultured cardiac
AC6 (D), collagen type I1 (E), and collagen type III1 (F) and also reduced
es above bars derived from Student t test (2-tailed) versus same condition for
AC6 knockdown; other abbreviations as in Figures 1, 2, 4, and 6.henyle
(C) an
ion of
p Valu
. KD ardiac myocyte FHL1 protein content. It was recently re-
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April 6, 2010:1476–86 Adenylyl Cyclase Knockout and Pressure Overloadorted that FHL1 deletion reduces Gq-induced ERK2 acti-
ation, reinduction of fetal gene expression, and cardiac hyper-
rophy (17). Our results, obtained in vivo and in isolated
ardiac myocytes, indicate that FHL1 may be an important
ediator for decreased cardiac myocyte hypertrophy after AC6
eduction.
Reduction of AC6 in cultured cardiac fibroblasts decreased
xpression of collagen types I and III (Figs. 8D to 8F),
ndicating that the effects of AC6 deletion on collagen expres-
ion and LV fibrosis in vivo resulted from cardiac fibroblasts
er se and did not require systemic changes in the renin-
ngiotensin-aldosterone axis. Associated with reduced fibro-
last collagen production was reduced periostin expression,
hich also was observed in vivo. Although it is not clear
hether periostin directly regulates expression of collagen types
and III, periostin deletion is associated with decreased cardiac
ollagen content in pressure-overloaded hearts (18). We infer
rom these results that, in addition to its role in modifying
ollagen fiber diameter and crosslinking, reduced periostin
xpression may mediate AC6 knockdown-reduced expression
f collagen types I and III.
C6 expression is beneficial in heart failure; AC6 dele-
ion is beneficial in pressure overload (in females). A key
nding in this study—that AC6 deletion is associated with
mproved LV function in pressure-overloaded hearts—was
ot anticipated. Indeed, because we have found consistently
hat increased cardiac AC6 content is associated with
eneficial effects in the failing heart (1,6–8), our hypothesis
as that its deletion, in the setting of pressure overload,
ould have unfavorable consequences. This unexpected
esult may reflect a variety of factors including: 1) Different
athophysiological models. LV dysfunction due to pressure
verload involves signaling pathways different from cardio-
yopathy. Thus, the expectation that reduced AC6 expres-
ion would have directionally opposite effects from increased
C6 expression independent of pathophysiological context
eems to be incorrect. 2) Differences in experimental strat-
gy vis-à-vis AC6 expression. In the present study, we
xplored the effects of AC6 deletion on the LV response to
ressure stress. In previous studies, we tested the effects of
C6 expression on a failing heart (1,6–8). One is a strategy
o determine the consequence of a gene deletion, the other
therapeutic challenge. It is not axiomatic that the results of
uch strategies should be directionally opposite. Finally,
C6 deletion has adverse effects in catecholamine-induced
ardiomyopathy associated with sustained isoproterenol in-
AC6 Knockdown, Phenylephrine, and Cardiac MTable 3 AC6 Knockdown, Phenylephrine, an
Cardiac Myocyte A
CON A
No phenylephrine 305 17 (n 89) 31
Phenylephrine (10 M, 16 h) 459 28 (n 83) 36
Values represent mean  SE. p values from 2-way analysis of varianc
CON  control mice.usion, in which LV hypertrophy, dilation, dysfunction, andncreased mortality are observed (unpublished data from our
aboratory, November 2009), indicating that the beneficial
ffects of AC6 deletion may be linked specifically with the
ressure-stressed heart.
n the AC6-deleted mouse, response to pressure overload
s different in males versus females. The higher mortality
ates in males was not determined, but correlates with early
V dysfunction and chamber dilation (see Online Supple-
ent). Although we do not have a precise mechanism for
his sex difference, the modulation of sex steroid hormones
n cardiac function is a plausible contributing factor in this
ortality difference (21).
tudy limitations. Although our studies have identified
ltered signaling pathways that likely are of mechanistic
mportance in the favorable adaptation of the female AC6-
eleted heart to pressure stress, the effect of prolonged
ressure stress, in excess of 3 weeks, was not studied but may
rovide additional important insights. For the terminal
tudy, we used pentobarbital in a high dose (100 mg/kg) to
btain the deep level of anesthesia demanded by our animal
se committee for surgical procedures. The consequent
egative inotropic effect likely influenced the LV physiolog-
cal studies, although other measures of LV contractile
unction (fractional shortening, ejection fraction, velocity of
ircumferential fiber shortening) confirm a group difference.
inally, we did not examine how intracellular cyclic aden-
sine monophosphate compartmentalization and concen-
rations (22) are altered by AC6 deletion—factors that may
e of additional mechanistic importance.
onclusions
he deleterious effects of sustained LV pressure overload
ere reduced in female mice with AC6 deletion. Reductions
n FHL1 and periostin expression, direct consequences of
educed AC6 in cardiac myocytes and fibroblasts, appear to
e of mechanistic importance for these unanticipated ben-
ficial effects.
eprint requests and correspondence: Dr. Tong Tang, VA San
iego Healthcare System (111A), 3350 La Jolla Village Drive, San
iego, California 92161. E-mail: ttang@vapop.ucsd.edu.
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